The Division of Occupational and Professional Licensing published a proposed rule to implement SB 177 and HB 178 enacted earlier this year, to amend the rule in accordance with Executive Order 2021-12 and to make changes consistent with Office of Administrative Rule’s current Rule Writing Manual. The deadline for written comments is January 14, 2022. Below is an outline of the various proposed amendments:
- Section R156-17b-102: to add definitions for “consulting pharmacist,” “designated representative,” and “responsible individual,” and clarify that compounding as defined in Section 58-17b-102(18) does not include adding flavoring agents to conventionally manufactured and commercially available liquid medication if the flavoring agents are therapeutically inert and do not exceed five percent of a preparation’s total volume.
- Sections R156-17b-601 and R156-17b-612: permits a pharmacy technician or pharmacy intern to transfer a legend prescription and permit dispensing of emergency prescriptions.
- Section R156-17b-603: to require a consulting pharmacist, PIG, RDPIC, or DMPIC to complete a self-audit after certain changes and prior to the end of a renewal cycle.
- Section R156-17b-614a: to clarity that the pharmacy department shall be equipped with a lock where drugs are stored.
- Section R156-17b-621a: to delete the continuing education requirement for pharmacists engaging in the administration of long-acting injectable drugs.
Also, the addition of Section R156-17b-627 defines operating standards for a pharmacist prescribing prescription drugs or devices.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.